Identity
- Security key
- 17745
- Ticker
- KLRA
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2026-04-17
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- KLRA
Detail
Enriched 2026-08-14 20:47
- Market cap
- $2,408,624,652.72
- Shares outstanding (class)
- 129,565,608
- Shares outstanding (weighted)
- 129,565,608
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- —
- Location
- WALTHAM, MA
- Homepage
- https://www.kailera.com
- Description
Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.
Market cap and share counts drift.